Othman Alharbi

899 total citations
58 papers, 628 citations indexed

About

Othman Alharbi is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Othman Alharbi has authored 58 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 19 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Othman Alharbi's work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (11 papers) and Colorectal Cancer Screening and Detection (6 papers). Othman Alharbi is often cited by papers focused on Inflammatory Bowel Disease (22 papers), Microscopic Colitis (11 papers) and Colorectal Cancer Screening and Detection (6 papers). Othman Alharbi collaborates with scholars based in Saudi Arabia, Canada and United States. Othman Alharbi's co-authors include Nahla Azzam, Majid A. Almadi, Abdulrahman Aljebreen, Narasimha Reddy Parine, Abdelhabib Semlali, Abdullah Alamri, Mohammad Alanazi, Maha Arafah, Mohammad Saud Alanazi and Mahmoud Mosli and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Othman Alharbi

54 papers receiving 617 citations

Peers

Othman Alharbi
Marcia S. Driscoll United States
Erin E. Perrone United States
Ai‐Xuan Holterman United States
Shameer Mehta United Kingdom
Othman Alharbi
Citations per year, relative to Othman Alharbi Othman Alharbi (= 1×) peers Daniela Simian

Countries citing papers authored by Othman Alharbi

Since Specialization
Citations

This map shows the geographic impact of Othman Alharbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Othman Alharbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Othman Alharbi more than expected).

Fields of papers citing papers by Othman Alharbi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Othman Alharbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Othman Alharbi. The network helps show where Othman Alharbi may publish in the future.

Co-authorship network of co-authors of Othman Alharbi

This figure shows the co-authorship network connecting the top 25 collaborators of Othman Alharbi. A scholar is included among the top collaborators of Othman Alharbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Othman Alharbi. Othman Alharbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sharara, Ala I., et al.. (2024). Attitudes, perceptions and barriers in implementing therapeutic drug monitoring for anti-TNFs in inflammatory bowel disease: a survey from the Middle East. Therapeutic Advances in Gastroenterology. 17. 1118413878–1118413878. 1 indexed citations
3.
Saadah, Omar I., Turki AlAmeel, Mohammed Hasosah, et al.. (2024). Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents. Saudi Journal of Gastroenterology. 31(3). 107–136. 2 indexed citations
5.
Azzam, Nahla, Abdulelah Almutairdi, Hajer Almudaiheem, et al.. (2023). Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy. Saudi Journal of Gastroenterology. 1 indexed citations
6.
Azzam, Nahla, et al.. (2023). Cost-Consequence Analysis of Colon Cancer Screening among Patients with Long-Standing Ulcerative Colitis: 11 Years’ Experience of Saudi Population. Saudi Pharmaceutical Journal. 31(12). 101883–101883. 1 indexed citations
7.
Azzam, Nahla, Abdulrahman Aljebreen, Othman Alharbi, et al.. (2021). Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort. Arab Journal of Gastroenterology. 22(1). 66–72. 1 indexed citations
8.
Alharbi, Othman, et al.. (2021). Severe Ludwig’s angina caused by an unknown insect bite. BMJ Case Reports. 14(8). e243566–e243566.
9.
Semlali, Abdelhabib, Mikhlid H. Almutairi, Abdullah Alamri, et al.. (2021). Expression and Polymorphism of TSLP/TSLP Receptors as Potential Diagnostic Markers of Colorectal Cancer Progression. Genes. 12(9). 1386–1386. 9 indexed citations
10.
Alharbi, Othman, Majid A. Almadi, Nahla Azzam, et al.. (2021). Clinical characteristics, natural history, and outcomes of Crohn's-related intra-abdominal collections. Saudi Journal of Gastroenterology. 27(2). 79–84. 3 indexed citations
11.
Alharbi, Othman, Ahmed S. BaHammam, Awad H. Olaish, et al.. (2021). Prevalence, severity and associated factors of restless leg syndrome in inflammatory bowel disease patients. Saudi Journal of Gastroenterology. 27(6). 348–354. 2 indexed citations
12.
Alanazi, Ibrahim O., Akbar Ali Khan, Narasimha Reddy Parine, et al.. (2020). Frequent Activation of Notch Signaling Pathway in Colorectal Cancers and Its Implication in Patient Survival Outcome. Journal of Oncology. 2020. 1–8. 18 indexed citations
14.
Azzam, Nahla, Yazed AlRuthia, Othman Alharbi, et al.. (2020). Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease. Hepatology International. 14(6). 1114–1124. 5 indexed citations
15.
Azzam, Nahla, Yazed AlRuthia, Othman Alharbi, et al.. (2020). <p>Predictors of Survival Among Colorectal Cancer Patients in a Low Incidence Area</p>. Cancer Management and Research. Volume 12. 451–459. 6 indexed citations
16.
AlRuthia, Yazed, Othman Alharbi, Abdulrahman Aljebreen, et al.. (2019). Drug utilization and cost associated with inflammatory bowel disease management in Saudi Arabia. Cost Effectiveness and Resource Allocation. 17(1). 25–25. 9 indexed citations
17.
Parine, Narasimha Reddy, Ibrahim O. Alanazi, Abdulrahman Aljebreen, et al.. (2019). TDG Gene Polymorphisms and Their Possible Association with Colorectal Cancer: A Case Control Study. Journal of Oncology. 2019. 1–9. 9 indexed citations
18.
Semlali, Abdelhabib, Mikhlid H. Almutairi, Akbar Ali Khan, et al.. (2019). Toll-like receptor 6 expression, sequence variants, and their association with colorectal cancer risk. Journal of Cancer. 10(13). 2969–2981. 14 indexed citations
19.
Semlali, Abdelhabib, Narasimha Reddy Parine, Nouf S. Al‐Numair, et al.. (2018). Potential role of Toll-like receptor 2 expression and polymorphisms in colon cancer susceptibility in the Saudi Arabian population. OncoTargets and Therapy. Volume 11. 8127–8141. 29 indexed citations
20.
Bazzi, Mohammad D., Sooad Al-Daihan, Mohammed Alanazi, et al.. (2018). The expression of telomere-related proteins and DNA damage response and their association with telomere length in colorectal cancer in Saudi patients. PLoS ONE. 13(6). e0197154–e0197154. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026